Company intelligence / Profile preview

CSI Companies

Ownership: Private
Development stage: Commercial

Overview

Provides end-to-end comparator sourcing and supply chain management for global Phase 1–3 trials. Case studies highlight successful support of complex oncology Phase 3 programs with timely delivery of high-value drugs like ruxolitinib across multiple countries.

Therapeutic areas: OtherOncology
Modalities: Small moleculeBiologicBiosimilarMedical device
Industry: Contract Research Organization

Partnerships

Top-ten pharmaceutical companiesleading biotechs worldwideCROsacademic institutions

Beyond the preview

Go deeper on CSI Companies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CSI Companies.

Explore the full profile